RNA-based co-transfer of human CD8αβ with WT1-specific TCRαβ redirects tumor recognition by CD4 and γδ T-cells towards MHC class I-restricted WT1 epitopes and boosts CD8 T-cell responses with or without CD3 mRNA
Source
Experimental hematology & oncology - ISSN 2162-3619-15:1 (2026) p. 1-6
Strategies to eliminate native T cell receptors for adoptive T cell therapies
Source
Molecular therapy - ISSN 1525-0016- (2026) p.
DRP1 depletion protects NK cells from hypoxia-induced dysfunction
Source
Redox report: communications in free radical research - ISSN 1351-0002-31:1 (2026) p. 1-20
Novel methods for the discovery of disease-associated T cell epitopes in autoimmunity
Source
Methods: a companion to methods in enzymology - ISSN 1046-2023-248 (2026) p. 64-82
From Imaging-to-Omics : a preclinical validation framework for advanced CNS therapeutics in Multiple Sclerosis: integrating in vivo MRI with post-mortem transcriptomics and proteomics
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, 2026,XV, 188 p.
Resilience of human tolerogenic dendritic cells to physiological oxygen supports clinical application : functional stability amidst glycolytic and differentiation shifts
Source
Experimental hematology & oncology - ISSN 2162-3619-15:1 (2026) p. 1-6
Time-series transcriptome analysis of the older adult mouse cochlea after noise-induced hearing loss reveals an acute immune response and recovery-associated pathways
Source
Molecular neurobiology - ISSN 0893-7648-63:1 (2026) p. 1-21
Comparative efficacy of talquetamab vs. real-world physician's choice of treatment in triple-class-exposed relapsed/refractory multiple myeloma : updated analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent
Source
Advances in therapy : the international journal of drug, device & diagnostic research - ISSN 0741-238X-43:1 (2026) p. 333-355
Generation of a homozygous and heterozygous iPSC line carrying a variant of uncertain significance in CACNA1C, associated with Brugada syndrome
Source
Stem cell research - ISSN 1873-5061-89 (2025) p. 1-8
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe
Source
Blood advances - ISSN 2473-9529-9:24 (2025) p. 6380-6393